A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

Sodium-glucose cotransporter 2 (SGLT2) inhibition seems to reduce the progression of nonsevere aortic stenosis over 5 years, with a larger treatment effect seen in those who take the drugs the longest ...

The SGLT2 inhibitors, as a class, lead to similar treatment benefits at comparable clinical doses, although there are some discrepancies between them, particularly when dapagliflozin (Farxiga; ...

According to a new national study, most children visiting hospital emergency departments with anaphylaxis, a severe and potentially life-threatening allergic reaction, could be discharged after two ...

Readmission rate improvements often attributed to an Affordable Care Act policy fining hospitals with higher-than-expected readmissions may actually be the result of changes in how visits were being ...

Patients revisiting the hospital within 30 days of initial discharge increasingly receive care in emergency departments and observation stays, marking a shift that may reflect hospitals’ efforts to ...